Harnessing nanoparticles for immunomodulation and vaccines
The first successful use of nanoparticles (NPs) for vaccination was reported almost 40 years ago with a virus-like particle-based vaccine against Hepatitis B. Since then, the term NP has been expanded to accommodate a large number of novel nano-sized particles engineered from a range of materials. T...
Autors principals: | Gomes, AC, Mohsen, M, Bachmann, M |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
MDPI
2017
|
Ítems similars
-
Synapse-directed delivery of immunomodulators using T-cell-conjugated nanoparticles
per: Stephan, Matthias T., et al.
Publicat: (2015) -
Biomaterial Strategies for Immunomodulation
per: Hotaling, Nathan A., et al.
Publicat: (2017) -
Delivering adjuvants and antigens in separate nanoparticles eliminates the need of physical linkage for effective vaccination.
per: Mohsen, M, et al.
Publicat: (2017) -
Immunomodulation using bacterial enterotoxins.
per: Simmons, C, et al.
Publicat: (2001) -
Harnessing the beneficial heterologous effects of vaccination.
per: Goodridge, H, et al.
Publicat: (2016)